Alpa Laboratories Limited (NSE:ALPA)
69.70
-1.72 (-2.41%)
Jun 1, 2026, 3:29 PM IST
Alpa Laboratories Market Cap
Alpa Laboratories has a market cap or net worth of 1.47 billion as of June 1, 2026. Its market cap has decreased by -33.58% in one year.
Market Cap
1.47B
Enterprise Value
112.89M
Revenue
1.22B
Ranking
n/a
PE Ratio
26.75
Stock Price
69.70
Market Cap Chart
Since August 7, 2007, Alpa Laboratories's market cap has increased from 1.15B to 1.47B, an increase of 27.19%. That is a compound annual growth rate of 1.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 1.47B | -10.28% |
| Dec 31, 2025 | 1.63B | -34.42% |
| Dec 31, 2024 | 2.49B | 14.68% |
| Dec 29, 2023 | 2.17B | 63.97% |
| Dec 30, 2022 | 1.33B | -20.65% |
| Dec 31, 2021 | 1.67B | 119.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 13.19B |
| Sigachi Industries | 8.14B |
| Valiant Laboratories | 4.21B |
| Bafna Pharmaceuticals | 3.12B |
| Nectar Lifesciences | 2.42B |
| Brooks Laboratories | 1.92B |
| Balaxi Pharmaceuticals | 1.45B |
| Par Drugs and Chemicals | 1.10B |